Barbara A. Zieba

981 total citations
18 papers, 548 citations indexed

About

Barbara A. Zieba is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Barbara A. Zieba has authored 18 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 5 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Barbara A. Zieba's work include Neuroscience and Neuropharmacology Research (9 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neuropeptides and Animal Physiology (4 papers). Barbara A. Zieba is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neuropeptides and Animal Physiology (4 papers). Barbara A. Zieba collaborates with scholars based in Poland, Germany and France. Barbara A. Zieba's co-authors include Maria Śmiałowska, Joanna M. Wierońska, Helena Domin, Krystyna Ossowska, Katarzyna Kuter, Jadwiga Wardas, Przemysław Nowak, Aleksandra Bortel, Jolanta Dąbrowska and Małgorzata Kajta and has published in prestigious journals such as Brain Research, Neuroscience and Annals of the Rheumatic Diseases.

In The Last Decade

Barbara A. Zieba

18 papers receiving 539 citations

Peers

Countries citing papers authored by Barbara A. Zieba

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Zieba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Zieba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Zieba more than expected).

Fields of papers citing papers by Barbara A. Zieba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Zieba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Zieba. The network helps show where Barbara A. Zieba may publish in the future.

Co-authorship network of co-authors of Barbara A. Zieba

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Zieba. A scholar is included among the top collaborators of Barbara A. Zieba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Zieba. Barbara A. Zieba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex 2021 ·Neuropeptides ·Maria Śmiałowska, Barbara A. Zieba, Helena Domin	5
2	Report of the first patient with a homozygous OTUD7A variant responsible for epileptic encephalopathy and related proteasome dysfunction 2020 ·Clinical Genetics ·(unknown), Frédéric Ebstein, Geoffroy Delplancq, (unknown), (unknown), Stéphane Auvin, Yannis Duffourd, (unknown), Barbara A. Zieba, (unknown), Karun K. Singh, Laurence Duplomb, Christel Thauvin‐Robinet, Jean‐Marc Costa, Elke Krüger, Detlef Trost, Alain Verloès, Laurence Faivre, Antonio Vitobello	18
3	The Proteasome System in Health and Disease 2020 ·Advances in experimental medicine and biology ·Olivier Coux, Barbara A. Zieba, Silke Meiners	21
4	AB1168 SIGLEC1/CD169 IS A SENSITIVE MARKER FOR MONOGENIC INTERFERONOPATHIES 2019 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Ellen Knierim, Angela M. Kaindl, Manuela Theophil, Axel Panzer, Barbara A. Zieba, Frédéric Ebstein, Elke Krüger, Nadine Unterwalder, Christian Meisel, Tilmann Kallinich	2
5	The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21 2018 ·Cell Reports ·Irina Lassot, (unknown), Suzanne Lesage, Barbara A. Zieba, (unknown), Christel Condroyer, Jozef P. Bossowski, Barbara Mojsa, Cécilia Marelli, (unknown), Christelle Tesson, Iria Carballo‐Carbajal, Ariadna Laguna, Graziella Mangone, Miquel Vila, Alexis Brice, Solange Desagher	30
6	The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin 2017 ·Journal of Dermatological Science ·Barbara A. Zieba, Laurent Henry, Matthieu Lacroix, Mohamed Jèmaà, Thierry Lavabre‐Bertrand, Laurent Meunier, Olivier Coux, Pierre‐Emmanuel Stoebner	12
7	Group III mGlu Receptor Agonist, ACPT-I, Exerts Potential Neuroprotective Effects In Vitro and In Vivo 2014 ·Neurotoxicity Research ·Helena Domin, Krystyna Gołembiowska, Danuta Jantas, Katarzyna Kamińska, Barbara A. Zieba, Maria Śmiałowska	18
8	Selective mGluR1 Antagonist EMQMCM Inhibits the Kainate-Induced Excitotoxicity in Primary Neuronal Cultures and in the Rat Hippocampus 2011 ·Neurotoxicity Research ·Maria Śmiałowska, Krystyna Gołembiowska, Małgorzata Kajta, Barbara A. Zieba, Anna Dziubina, Helena Domin	25
9	9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease 2010 ·Pharmacological Reports ·Catrin Wernicke, (unknown), Barbara A. Zieba, Katarzyna Kuter, Krystyna Ossowska, Monika Frenzel, Norbert A. Dencher, Hans Rommelspacher	43
10	Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus 2010 ·Pharmacological Reports ·Helena Domin, Barbara A. Zieba, Krystyna Gołembiowska, (unknown), Anna Dziubina, Maria Śmiałowska	21
11	Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo 2009 ·Neuropeptides ·Maria Śmiałowska, Helena Domin, Barbara A. Zieba, Ewa Koźniewska, (unknown), Piotr Piotrowski, Małgorzata Kajta	56
12	The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats 2008 ·Neuroscience ·Elżbieta Lorenc‐Koci, Lucyna Antkiewicz‐Michaluk, Anna Kamińska, Tomasz Lenda, Barbara A. Zieba, Joanna M. Wierońska, Maria Śmiałowska, G. Schulze, Hans Rommelspacher	12
13	The behavioural and electrophysiological effects of CRF in rat frontal cortex 2008 ·Neuropeptides ·Barbara A. Zieba, (unknown), Piotr Brański, Helena Domin, Joanna M. Wierońska, Grzegorz Hess, Maria Śmiałowska	18
14	Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats 2007 ·Brain Research ·Katarzyna Kuter, Maria Śmiałowska, Joanna M. Wierońska, Barbara A. Zieba, Jadwiga Wardas, M. Pietraszek, Przemysław Nowak, (unknown), Wojciech Roczniak, Jolanta Konieczny, Stanisław Wolfarth, Krystyna Ossowska	63
15	Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson’s disease 2006 ·Neuroscience ·Krystyna Ossowska, Maria Śmiałowska, Katarzyna Kuter, Joanna M. Wierońska, Barbara A. Zieba, Jadwiga Wardas, Przemysław Nowak, Jolanta Dąbrowska, Aleksandra Bortel, (unknown), G. Schulze, Hans Rommelspacher	60
16	The Effect of Intrahippocampal Injection of Group II and III Metobotropic Glutamate Receptor Agonists on Anxiety; the Role of Neuropeptide Y 2006 ·Neuropsychopharmacology ·Maria Śmiałowska, Joanna M. Wierońska, Helena Domin, Barbara A. Zieba	40
17	A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease? 2005 ·European Journal of Neuroscience ·Krystyna Ossowska, Jadwiga Wardas, Maria Śmiałowska, Katarzyna Kuter, Tomasz Lenda, Joanna M. Wierońska, Barbara A. Zieba, Przemysław Nowak, Jolanta Dąbrowska, Aleksandra Bortel, (unknown), S. Wolfarth	103
18	P.1.23 The long-term paraquat administration produces a slowly progressing degeneration of the nigrostriatal system in rats 2005 ·European Neuropsychopharmacology ·Katarzyna Kuter, Jadwiga Wardas, (unknown), Jolanta Dąbrowska, Aleksandra Bortel, (unknown), Tomasz Lenda, Maria Śmiałowska, Joanna M. Wierońska, Barbara A. Zieba, S. Wolfarth, Krystyna Ossowska	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact